Taken together, these data suggest that, in Merlin-deficient schwannoma cells, Group I PAK inhibition blocks proliferation and TEAD inhibition promotes cell death, specifically apoptosis, suggesting a rationale for combining these agents. The gene discussed is NF2; the disease is schwannoma.